Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Groupon
GRPN
$1.02B
| $221K | ﹤0.01% |
9,676
+1,619
| +20% | +$47.9K |
|
|
NGM
2652
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $221K | ﹤0.01% |
10,518
+6,063
| +136% | +$133K |
|
2653
KALA BIO
KALA
$14.5M
| $220K | ﹤0.01% |
34
+28
| +467% | +$242K |
|
|
RAPT
2654
DELISTED
RAPT Therapeutics
RAPT
| $220K | ﹤0.01% |
883
+502
| +132% | +$133K |
|
2655
Angi Inc
ANGI
$196M
| $219K | ﹤0.01% |
1,773
+1,434
| +423% | +$165K |
|
2656
Johnson Outdoors
JOUT
$505M
| $219K | ﹤0.01% |
2,076
+1,132
| +120% | +$129K |
|
2657
CarParts.com
PRTS
$54.7M
| $219K | ﹤0.01% |
1,407
+725
| +106% | +$126K |
|
2658
Arrow Financial
AROW
$652M
| $218K | ﹤0.01% |
6,720
+3,533
| +111% | +$116K |
|
2659
Ennis
EBF
$564M
| $218K | ﹤0.01% |
11,539
+5,152
| +81% | +$101K |
|
|
PETQ
2660
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $218K | ﹤0.01% |
8,766
+4,747
| +118% | +$143K |
|
2661
First Community Bankshares
FCBC
$911M
| $217K | ﹤0.01% |
6,837
+3,152
| +86% | +$95.2K |
|
2662
Sociedad Química y Minera de Chile
SQM
$20.6B
| $217K | ﹤0.01% |
4,033
| – | – |
|
2663
Vishay Precision Group
VPG
$914M
| $217K | ﹤0.01% |
6,240
+2,488
| +66% | +$90.3K |
|
2664
Boston Omaha
BOC
$436M
| $216K | ﹤0.01% |
5,568
+3,481
| +167% | +$115K |
|
2665
Sterling Infrastructure
STRL
$16.7B
| $216K | ﹤0.01% |
9,542
+5,554
| +139% | +$124K |
|
2666
Agilon Health
AGL
$1.6B
| $215K | ﹤0.01% |
327
+47
| +17% | +$40.1K |
|
2667
NRC Health Common Stock
NRC
$450M
| $215K | ﹤0.01% |
5,091
+2,735
| +116% | +$138K |
|
2668
Sana Biotechnology
SANA
$980M
| $215K | ﹤0.01% |
9,558
+6,096
| +176% | +$128K |
|
2669
Select Water Solutions
WTTR
$2.61B
| $215K | ﹤0.01% |
41,299
+12,161
| +42% | +$66.9K |
|
2670
UWM Holdings
UWMC
$434M
| $214K | ﹤0.01% |
30,860
+22,654
| +276% | +$169K |
|
2671
Fomento Económico Mexicano
FMX
$41.7B
| $213K | ﹤0.01% |
2,458
| – | – |
|
2672
Sutro Biopharma
STRO
$421M
| $213K | ﹤0.01% |
1,127
+635
| +129% | +$121K |
|
2673
Cue Biopharma
CUE
$114M
| $211K | ﹤0.01% |
484
+180
| +59% | +$62.8K |
|
2674
Vaxcyte
PCVX
$8.64B
| $210K | ﹤0.01% |
8,256
+4,124
| +100% | +$100K |
|
2675
Arcutis Biotherapeutics
ARQT
$3.18B
| $209K | ﹤0.01% |
8,732
+4,949
| +131% | +$113K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.